Log In
Print
BCIQ
Print
Print this Print this
 

Atu027

  Manage Alerts
Collapse Summary General Information
Company Silence Therapeutics plc
DescriptionLiposomal small interfering RNA (siRNA) formulation targeting protein kinase N3 (PKN3)
Molecular Target Protein kinase N3 (PKN3)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today